Olema Pharmaceuticals (NASDAQ:OLMA) Earns “Buy” Rating from HC Wainwright
Olema Pharmaceuticals (NASDAQ:OLMA – Get Free Report)‘s stock had its “buy” rating restated by stock analysts at HC Wainwright in a note issued to investors on Wednesday,Benzinga reports. They presently have a $30.00 price objective on the stock. HC Wainwright also issued estimates for Olema Pharmaceuticals’ FY2029 earnings at ($2.41) EPS. Olema Pharmaceuticals Price Performance […]
Olema Pharmaceuticals (NASDAQ:OLMA – Get Free Report)‘s stock had its “buy” rating restated by stock analysts at HC Wainwright in a note issued to investors on Wednesday,Benzinga reports. They presently have a $30.00 price objective on the stock. HC Wainwright also issued estimates for Olema Pharmaceuticals’ FY2029 earnings at ($2.41) EPS. Olema Pharmaceuticals Price Performance […]
